Long-term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome.

Magdy El-SalhyAnja Bråthen KristoffersenJørgen ValeurChristina CasenJan Gunnar HatlebakkOdd Helge GiljaTrygve Hausken

Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2021)

Most of the IBS patients maintained a response at 1 year after FMT. Moreover, the improvements in symptoms and quality of life increased over time. Changes in DI, fecal bacterial profile and SCFAs were more comprehensive at 1 year than after 3 months. www.clinicaltrials.gov (NCT03822299).

Keyphrases

irritable bowel syndrome
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
stem cells
escherichia coli
pseudomonas aeruginosa
mesenchymal stem cells
cystic fibrosis
candida albicans